Physical Examination Recommendations for Type 2 Diabetes Mellitus

Diagnosis‑time Comprehensive Examination

• The American Diabetes Association (ADA) recommends that at the time of diagnosis a complete physical examination be performed, including blood pressure measurement, body‑mass‑index (BMI) calculation, a detailed foot examination with 10‑g monofilament testing, assessment for acanthosis nigricans, and a dilated eye examination by an ophthalmologist shortly after diagnosis. 1
• Blood pressure should be measured at the initial visit because hypertension is common in people with type 2 diabetes and early optimization reduces micro‑ and macrovascular complications. [1][2]
• BMI should be recorded at diagnosis to stratify cardiovascular and metabolic risk; patients with BMI > 35 kg/m² may be considered for metabolic (bariatric) surgery. [3][1]
• A comprehensive foot examination at diagnosis must include: visual inspection for deformities, skin breakdown, calluses or ulcers; palpation of dorsalis pedis and posterior tibial pulses; 10‑g monofilament testing for loss of protective sensation; vibration testing with a 128‑Hz tuning fork; pinprick sensation testing; and ankle reflex assessment. [4][1][4][1]2
• All adults with type 2 diabetes should be screened for distal symmetric polyneuropathy at diagnosis using the structured foot examination described above. 4

Annual Follow‑up Examination

• Blood pressure must be measured at every routine visit (not only annually); hypertension in adults is defined as ≥130/80 mmHg and warrants lifestyle modification and, when needed, pharmacologic therapy. [1][3]
• Weight and BMI should be documented annually to detect clinically important changes that may require treatment intensification. [3][1]
• The full foot examination (inspection, pulse assessment, monofilament, vibration, pinprick, ankle reflex) should be repeated each year to identify progression of neuropathy or peripheral arterial disease early. [1][2]4
• Dilated comprehensive eye examination should be repeated annually if diabetic retinopathy is present, or every two years if glycemic control is adequate and the prior exam was normal. [1][2]

Specialist Referral Triggers

• Patients identified with loss of protective sensation, structural foot abnormalities, a history of foot ulceration, or peripheral arterial disease should be referred to a podiatry/foot‑care specialist for lifelong preventive management. 4
• A dilated eye examination performed shortly after diagnosis reveals that up to 30 % of individuals already have diabetic retinopathy and about 3 % have clinically significant macular edema, warranting prompt ophthalmology referral. 5
• Referral to nephrology is indicated when there is a worsening urine albumin‑to‑creatinine ratio or a decline in estimated glomerular filtration rate. 1

Additional Targeted Physical Assessments

• Thyroid palpation at diagnosis is advised because autoimmune thyroid disease occurs more frequently in people with diabetes, especially type 1, but also in type 2. 6
• Hepatomegaly should be assessed by palpation; non‑alcoholic fatty liver disease is prevalent in type 2 diabetes and should be evaluated with liver‑enzyme testing at diagnosis and annually. [1][2]
• Screening for obstructive sleep‑apnea symptoms (snoring, witnessed apneas, daytime somnolence, morning headaches) should occur at each visit, with referral to a sleep specialist when indicated. [3][1]2

Common Pitfalls to Avoid

• Do not omit the comprehensive foot examination in younger or asymptomatic patients; neuropathy screening must begin at diagnosis for all adults with type 2 diabetes. 4
• Do not rely solely on patient‑reported symptoms for neuropathy detection, as many individuals have asymptomatic loss of protective sensation detectable only by structured examination. 4
• Do not limit blood‑pressure measurement to annual visits; it should be performed at every routine encounter to optimize cardiovascular risk reduction. 1
• Do not order routine screening electrocardiograms, echocardiograms, or stress tests in asymptomatic youth or adults with type 2 diabetes, as these are not recommended. 1

Initial Investigations for Newly Diagnosed Type 2 Diabetes

Immediate Laboratory Investigations

• The American Diabetes Association recommends HbA1c measurement to establish baseline glycemic control and confirm diagnosis if not already done (≥6.5% diagnostic) 7
• Fasting plasma glucose is recommended if HbA1c was not the initial diagnostic test 7
• Urine albumin-to-creatinine ratio (UACR) in a random spot collection is the preferred method over 24-hour collections for renal function screening 8, 9, 10
• Serum creatinine with calculated eGFR is used to assess kidney function and stage any chronic kidney disease 8, 11, 7
• Serum potassium is measured as baseline, particularly important before initiating certain medications 11

Cardiovascular Risk Assessment

• A complete lipid profile, including LDL cholesterol, HDL cholesterol, total cholesterol, and triglycerides, is recommended to determine the need for statin therapy and cardiovascular risk stratification 7
• Blood pressure measurement is used to assess for hypertension 7

Immediate Specialist Referrals

• The American Academy of Ophthalmology recommends a dilated comprehensive eye examination by an ophthalmologist or optometrist shortly after diagnosis, including visual acuity testing, slit-lamp biomicroscopy, intraocular pressure measurement, gonioscopy, stereoscopic examination of the posterior pole, and peripheral retinal examination via indirect ophthalmoscopy 12
• Up to 30% of type 2 diabetes patients have retinopathy at diagnosis, and 3% already have clinically significant macular edema or high-risk features requiring immediate intervention 12

Additional Essential Screening

• The American Diabetes Association recommends a comprehensive foot examination, including inspection, assessment of foot pulses, and testing for loss of protective sensation using at least one of: 10-g monofilament, vibration testing with 128-Hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold 7
• Screening for distal symmetric polyneuropathy should begin at diagnosis in type 2 diabetes 7

Special Considerations for a 32-Year-Old Patient

• The American College of Endocrinology recommends considering antibody testing to distinguish type 1 from type 2 diabetes if there is any phenotypic overlap, including GAD, IA-2, and ZnT8 antibodies, and C-peptide testing if already on insulin or if classification remains uncertain after antibody testing 13
• Pregnancy planning counseling is essential for a 32-year-old female, as pre-existing diabetes requires comprehensive eye examination before conception and close monitoring throughout pregnancy 8, 9

Monitoring Schedule After Initial Workup

• Annual screening is recommended for UACR, serum creatinine/eGFR, comprehensive eye examination, foot examination, and lipid profile 8, 11, 10, 7
• More frequent monitoring is recommended if abnormalities are detected, including eGFR every 3-6 months if stage 3-4 CKD, and eye exams every 3-12 months if retinopathy is present 14, 11, 10